Table 2.
Number of CSF and serum samples analysed for each signalling protein in each group
|
Groups |
IL-6 |
VEGF |
TGF-ß1 |
|||
|---|---|---|---|---|---|---|
| n of samples | CSF | Serum | CSF | Serum | CSF | Serum |
|
SRMA |
26 |
28 |
21 |
28 |
36 |
35 |
|
SRMA R |
9 |
8 |
9 |
8 |
0 |
0 |
|
SRMA Th |
41 |
44 |
41 |
45 |
0 |
0 |
|
ME |
13 |
13 |
11 |
17 |
39 |
35 |
|
CNS-Mix |
21 |
22 |
18 |
20 |
29 |
26 |
|
Syst. Inflam. |
7 |
12 |
3 |
16 |
0 |
0 |
|
IE |
22 |
16 |
14 |
14 |
0 |
0 |
| Healthy | 8 | 8 | 8 | 8 | 20 | 15 |
IL-6: interleukin-6; VEGF: vascular endothelial grow factor; TGF-β1: Transforming growth factor beta; CSF: cerebrospinal fluid; CNS: central nervous system; SRMA: steroid-responsive meningitis-arteritis; Syst Inflam: systemic inflammatory diseases; ME: other inflammatory CNS diseases; CNS-Mix: miscellaneous non-inflammatory CNS diseases; IE: idiopathic epilepsy.